| Sofinnova Partners. (3/18/25). "Press Release: Sofinnova Partners Exceeds Target with €165M Biotech Acceleration Fund, Europe’s Largest, with Strong Pharma Support". Paris. |
2025-03-18 |
| [iito] Business Intelligence. (3/18/25). "Press Release: [iito] Business Intelligence Announces Major Changes in Its Social Media Strategy". Bremen. |
2025-03-18 |
| EsoBiotec SA. (3/17/25). "Press Release: EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition". Mont-Saint-Guibert. |
2025-03-17 |
| Centogene N.V.. (3/12/25). "Press Release: Centogene Closes Strategic Transaction with Private Equity Group Charme Capital Partners". Cambridge, MA, Rostock & Berlin. |
2025-03-12 |
| Trimtech Therapeutics Ltd.. (3/5/25). "Press Release: Trimtech Therapeutics Raises $31M Seed Funding to Advance Targeted Protein Degradation Pipeline for Treatment of Neurodegenerative Diseases". Cambridge. |
2025-03-05 |
| Corden Pharma International GmbH. (3/5/25). "Press Release: CordenPharma Expands Peptide Platform with >€500m Greenfield Facility Construction in the Basel Region of Switzerland". Basel. |
2025-03-05 |
| Forbion Capital Partners. (3/3/25). "Press Release: Forbion Expands US Presence with the Appointment of Regina Salvat, PhD, as Principal in the Boston Office". Naarden. |
2025-03-03 |
| Qiagen N.V.. (3/3/25). "Press Release: Qiagen Takes Legal Action to Defend QuantiFERON Intellectual Property and Protect Innovations in Latent Tuberculosis Testing". Venlo. |
2025-03-03 |
| VarmX B.V.. (2/25/25). "Press Release: VarmX Awarded €15 Mln Follow-on Equity Investment by the EIC Accelerator". Leiden. |
2025-02-25 |
| Ion Opticks Pty Ltd.. (2/24/25). "Press Release: IonOpticks Announces Strategic Global Expansion with Key Leadership Appointments". Melbourne. |
2025-02-24 |
| Ginkgo Bioworks Inc.. (2/20/25). "Press Release: Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care". Boston, MA. |
2025-02-20 |
| Atai Life Sciences AG. (2/20/25). "Press Release: Atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares". New York, NY & Berlin. |
2025-02-20 |
| Vivalyx GmbH. (2/19/25). "Press Release: Vivalyx Backed by EIC Accelerator with up to €8.5M to Advance Organ Revitalization Technology". Aachen. |
2025-02-19 |
| Qiagen N.V.. (2/13/25). "Press Release: Qiagen Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region". Venlo & Redwood City, CA. |
2025-02-13 |
| TME Pharma N.V.. (1/29/25). "Press Release: TME Pharma Announces Collaboration with Aimed Analytics for AI-Driven Drug Discovery and Optimization". Berlin. |
2025-01-29 |
| Forbion Capital Partners. (1/27/25). "Press Release: Forbion BioEconomy Fund I Surpasses €150 Million Target, Raising €164.5 Million with Strong Institutional LP Support". Naarden. |
2025-01-27 |
| Pharming Group N.V.. (1/21/25). "Press Release: Pharming to Nominate Biopharmaceutical Leader Fabrice Chouraqui as New Executive Director and Chief Executive Officer". Leiden. |
2025-01-21 |
| European Invesmtent Bank (EIB). (1/14/25). "Press Release: Germany – EIB Provides €35 Million to Formo to Expand Production of Cheese Alternatives Free from Animal Products". |
2025-01-14 |
| Forbion Capital Partners. (1/13/25). "Press Release: Forbion Promotes Dirk Kersten to Managing Partner and Strengthens US Team". Naarden. |
2025-01-13 |
| CoreMedic GmbH. (1/10/25). "Press Release: CoreMedic Announces Partnership with InnoRa for Clinical Development of Transcatheter Mitral Valve Repair Device ChordArt". Basel & Philadelphia, PA. |
2025-01-10 |
| RhyGaze AG. (1/10/25). "Press Release: Institute of Molecular and Clinical Ophthalmology Basel Spinout RhyGaze Closes USD 86 Million Series A Round to Further Novel Gene Therapy for Vision Restoration". Basel & Philadelphia, PA. |
2025-01-10 |
| Numab Therapeutics AG. (1/9/25). "Press Release: Numab Therapeutics Announces Series C Extension to CHF 180 Million, Completing Oversubscribed CHF 50 Million Financing". Horgen. |
2025-01-09 |
| BioLizard N.V.. (1/9/25). "Press Release: BioLizard Welcomes Arjan van Manen as Commercial Director and Announces Presence at JPM Week in San Francisco". Ghent. |
2025-01-09 |
| Alesta Therapeutics B.V.. (1/8/25). "Press Release: Alesta Therapeutics Raises €65 Million Series A Financing to Advance Oral Small Molecules for Rare Diseases". Leiden. |
2025-01-08 |
| Orbis Medicines ApS. (1/6/25). "Press Release: Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles". Copenhagen. |
2025-01-06 |
| Evaxion Biotech A/S. (12/17/24). "Press Release: Evaxion Pursues Agreement with EIB to Bolster Equity through Conversion of Debt into Equity". Copenhagen. |
2024-12-17 |
| Merck KGaA. (12/17/24). "Press Release: Merck to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio". Darmstadt. |
2024-12-17 |
| VectorY Therapeutics B.V.. (12/16/24). "Press Release: VectorY Strengthens Leadership Team with Appointment of Jim Scibetta as New CEO". Amsterdam & Boston, MA. |
2024-12-16 |
| Gilde Healthcare Partners. (12/16/24). "Press Release: Gilde Healthcare Invests alongside Capital A in Tromp Medical to Accelerate International Growth in the Medical Imaging Market". Utrecht. |
2024-12-16 |
| Mainz Biomed N.V.. (12/16/24). "Press Release: Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering". Berkeley, CA & Mainz. |
2024-12-16 |
| Pharming Group N.V.. (12/15/24). "Press Release: Pharming Announces Public Cash Offer to the Shareholders of Abliva AB". Leiden. |
2024-12-15 |
| Andera Partners. (12/12/24). "Press Release: New York Life Investments and Its European Affiliate, Candriam, Announce Strategic Partnership with Andera Partners". New York, NY, Paris & Brussels. |
2024-12-12 |
| Kadans Science Partner. (12/12/24). "Press Release: Kadans Science Partner with the Support of Accumulata to Transform Former Signa Property into Life Science Innovation Hub". Berlin. |
2024-12-12 |
| EQT AB. (12/11/24). "Press Release: EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million". |
2024-12-11 |
| BenevolentAI Ltd.. (12/11/24). "Press Release: BenevolentAI Unveils Major Strategic Overhaul with Return to Original Mission". London. |
2024-12-11 |
| Citryll B.V.. (12/9/24). "Press Release: Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders". Oss. |
2024-12-09 |
| Muna Therapeutics ApS. (12/5/24). "Press Release: Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease". Copenhagen. |
2024-12-05 |
| Abselion (HexagonFab Ltd.). (12/4/24). "Press Release: Abselion Raises £6.6 Million Led by M Ventures to Bring Disruptive At-line Protein Analyser, Amperia, to Market". Cambridge. |
2024-12-04 |
| miDiagnostics N.V.. (12/4/24). "Press Release: miDiagnostics Secures €30 Million Series D Funding Round Led by Thermo Fisher Scientific to Advance an Innovative Sterility Test and Other Quality Control Tests for use in the BioPharma Industry". Leuven. |
2024-12-04 |
| TME Pharma N.V.. (12/4/24). "Press Release: (CORRECTING and REPLACING) TME Pharma Announces Corporate Strategy Update and Upcoming €2.6 Million Guaranteed Financing With Intention to Launch Public Offer Open Only to Shareholders to Enable Completion of T |
2024-12-04 |
| Mainz Biomed N.V.. (11/29/24). "Press Release: Mainz Biomed Announces Stock Split". Berkeley, CA & Mainz. |
2024-11-29 |
| Bio Inx B.V.. (11/27/24). "Press Release: Bio Inx and Carl Roth Partner to Expand Access to 3D Bioprinting Solutions". Ghent. |
2024-11-27 |
| Cradle Bio B.V.. (11/26/24). "Press Release: Cradle Raises $73m Series B Led by IVP to Accelerate Adoption of AI-powered Protein Engineering". Amsterdam & Zurich. |
2024-11-26 |
| Adcendo ApS. (11/25/24). "Press Release: Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline". Copenhagen. |
2024-11-25 |
| Centogene N.V.. (11/13/24). "Press Release: Centogene Signs Strategic Transaction with Private Equity Group Charme Capital Partners [not for release, publication or distribution, where unlawful]". Cambridge, MA & Rostock. |
2024-11-13 |
| BioNTech SE. (11/13/24). "Press Release: BioNTech to Acquire Biotheus to Boost Oncology Strategy". Mainz. |
2024-11-13 |
| [iito] Business Intelligence / Kääb, Georg [ Itranskript ]. (11/13/24). "[LSG] Newsletter Special Issue: DACH Region Seed Financings 2020–2024. A List of 104 Deals with Comment & Analysis by Georg Kääb". Bremen & München. |
2024-11-13 |
| VarmX B.V.. (11/12/24). "Press Release: VarmX Announces Appointment of John Glasspool as CEO". Leiden. |
2024-11-12 |
| High-Tech Gründerfonds Management GmbH. (11/12/24). "Press Release: Zymofix Secures €2 Million to Scale Microbial Solutions for Sustainable Agriculture and Beyond". Ghent. |
2024-11-12 |
| Mainz Biomed N.V.. (11/12/24). "Press Release: Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets". Berkeley, CA & Mainz. |
2024-11-12 |
| TME Pharma N.V.. (10/31/24). "Press Release: TME Pharma Awarded €2.4 Million German Federal Grant to Support NOX-A12 Phase 2 Trial in Brain Cancer". Berlin. |
2024-10-31 |
| Kivu Bioscience. (10/28/24). "Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates". San Francisco, CA. |
2024-10-28 |
| Forbion Capital Partners. (10/15/24). "Press Release: Forbion Raises in Excess of €2 Billion for Two New Funds". Naarden. |
2024-10-15 |
| Cosmo Pharmaceuticals N.V.. (10/11/24). "Press Release: Cosmo Pharmaceuticals Appoints New Chief Financial Officer". Dublin. |
2024-10-11 |
| Immatics N.V.. (10/10/24). "Press Release: Immatics Announces Proposed $150 Million Public Offering". Houston, TX & Tübingen. |
2024-10-10 |
| Lumicks Technologies B.V.. (10/10/24). "Press Release: Dutch Life Science Tools [Company] Lumicks Secures €20 Million from European Investment Bank to Accelerate Drug Discovery for Cancer". |
2024-10-10 |
| Immatics N.V.. (10/10/24). "Press Release: Immatics Announces Updated Phase 1b Clinical Data on ACTengine IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial". Houston, TX & Tübingen. |
2024-10-10 |
| Purespring Therapeutics Ltd.. (10/9/24). "Press Release: Purespring Therapeutics Raises £80/$105 Million in a Series B Financing to Transform the Treatment of Kidney Diseases". London. |
2024-10-09 |
| Calluna Pharma AS. (10/9/24). "Press Release: Calluna Pharma Appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board". Oslo & Boston, MA. |
2024-10-09 |
| Enara Bio Ltd.. (10/3/24). "Press Release: Enara Bio Raises $32.5 Million Series B Financing to Advance First-in-Class Pipeline of TCR-based Immunotherapies Targeting Novel Dark Antigens". Oxford. |
2024-10-03 |
| LoQus23 Therapeutics Ltd.. (10/2/24). "Press Release: LoQus23 Therapeutics Announces £35 Million (c.$43 Million) Series A Financing to Advance Its Small Molecule Somatic Expansion Inhibition Therapy for Huntington’s Disease". Cambridge. |
2024-10-02 |
| TME Pharma N.V.. (9/30/24). "Press Release: TME Pharma Announces Appointment of Alexandra Glucksmann to Supervisory Board". Berlin. |
2024-09-30 |
| Halix B.V.. (9/19/24). "Press Release: Halix Appoints Dr. Lutz Hilbrich as New Chief Executive Officer". Leiden. |
2024-09-19 |
| Noah Labs GmbH. (9/19/24). "Press Release: Noah Labs Receives €3 Million in Financing Round Led by Nina Capital". Berlin & Potsdam. |
2024-09-19 |
| Qiagen N.V.. (9/18/24). "Press Release: Qiagen Expands QIAcuity Digital PCR Offering with over New 100 Assays via GeneGlobe Platform". Venlo. |
2024-09-18 |
| Organon & Co.. (9/18/24). "Press Release: Organon to Acquire Dermavant including Its Innovative Dermatologic Therapy, Vtama (tapinarof) Cream, 1%". Jersey City, NJ. |
2024-09-18 |
| ImmunOs Therapeutics AG. (9/17/24). "Press Release: ImmunOs Therapeutics AG Raises $11 Million and Further Strengthens Investor Base". |
2024-09-17 |
| Bioké (Cell Signaling Technology Europe B.V.). (9/16/24). "Press Release: Bioké and e-Blot Announce a Distribution Agreement in the European Region". Leiden. |
2024-09-16 |
| Novameat Tech SL. (9/12/24). "Press Release: Novameat Raises €17.4M Oversubscribed Series A Round Led by Sofinnova Partners and Forbion". Barcelona. |
2024-09-12 |
| Organon & Co.. (9/12/24). "Press Release: Organon Enters into Licensing Agreement with Bao Pharmaceutical and Its Wholly-owned Subsidiary Centergene Pharmaceuticals". Shanghai. |
2024-09-12 |
| Abolis Biotechnologies SAS. (9/12/24). "Press Release: Abolis Biotechnologies Secures 35 Mio. Euro from International Consortium of Industrials and Funds". Èvry-Courcouronnes. |
2024-09-12 |
| Qiagen N.V.. (9/12/24). "Press Release: Qiagen and Bio-Manguinhos/Fiocruz Collaborate to Enhance Malaria and Dengue Detection in Brazil’s National Screening Programs". Venlo & Rio de Janeiro. |
2024-09-12 |
| Inflammatix, Inc.. (9/12/24). "Press Release: Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis". Sunnyvale, CA. |
2024-09-12 |
| Ion Beam Applications S.A. (IBA). (9/11/24). "Press Release: IBA’s Joint Venture PanTera Secures EUR 93 Million in Oversubscribed Series A Round to Accelerate Global Actinium-225 Production". Louvain-la-Neuve. |
2024-09-11 |
| Forbion Capital Partners. (9/11/24). "Press Release: Forbion Leads $14m Series A in Solasta Bio to Advance Development and Commercialisation of First-in-class Sustainable Crop Protection Solutions". Naarden. |
2024-09-11 |
| Mainz Biomed N.V.. (9/4/24). "Press Release: Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert". Berkeley, CA & Mainz. |
2024-09-04 |
| Qiagen N.V.. (9/4/24). "Press Release: Qiagen and Lilly Collaborate to Support Development of a QIAstat-Dx IVD Panel that Identifies Patients at Risk for Developing Alzheimer’s disease". Venlo. |
2024-09-04 |
| Qiagen N.V.. (9/3/24). "Press Release: Qiagen N.V. Announces Successful Placement of New Net Share Settled Convertible Bonds [not for US, CA, AU, JP, ZA, et al.]". Venlo. |
2024-09-03 |
| Organon & Co.. (9/3/24). "Press Release: Organon Appoints Daniel Karp as Executive Vice President, Corporate Development". Jersey City, NJ. |
2024-09-03 |
| Gilde Healthcare Partners. (9/2/24). "Press Release: Gilde Healthcare Appoints Jan Willem Bakker as Head of Investor Relations". Utrecht. |
2024-09-02 |
| Qiagen N.V.. (8/28/24). "Press Release: Qiagen Expands QIAstat-Dx into Precision Medicine through Partnership for Companion Diagnostics in Chronic Diseases". Venlo. |
2024-08-28 |
| InflaRx N.V.. (8/27/24). "Press Release: InflaRx Announces Participation in September Investor Events". Jena. |
2024-08-27 |
| Caresyntax. (8/15/24). "Press Release: Caresyntax Raises $180 Million Funding to Accelerate Growth and Adoption of Precision Surgery". San Francisco, CA & Berlin. |
2024-08-15 |
| PL BioScience GmbH. (8/8/24). "Press Release: PL BioScience Closes € 7.8 million Series A Financing". Aachen. |
2024-08-08 |
| Centogene N.V.. (8/7/24). "Press Release: Centogene Receives Delisting Notice From Nasdaq". Cambridge, MA, Rostock & Berlin. |
2024-08-07 |
| AGC Biologics. (8/7/24). "Press Release: NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines". |
2024-08-07 |
| Immatics N.V.. (7/31/24). "Press Release: Immatics Appoints Alise Reicin to Board of Directors". Houston, TX & Tübingen. |
2024-07-31 |
| AIRNA Corporation. (7/31/24). "Press Release: AIRNA Raises Oversubscribed $60 Million Financing to Advance New Class of RNA Editing Medicines and Progress Best-in-Class AATD Program into the Clinic". Cambridge, MA & Tübingen. |
2024-07-31 |
| Confo Therapeutics N.V.. (7/26/24). "Press Release: Confo Therapeutics Announces EUR 60M Series B Financing to Advance a Pipeline of Novel GPCR-Modulating Therapies into Clinical Development". Ghent. |
2024-07-26 |
| TME Pharma N.V.. (7/22/24). "Press Release: TME Pharma Announces Strategic Plan to Externalize and Monetize Second Clinical Stage Asset NOX-E36". Berlin. |
2024-07-22 |
| Addex Therapeutics S.A.. (7/22/24). "Press Release: Addex’s Partner Discontinues ADX71149 Development in Epilepsy". Geneva. |
2024-07-22 |
| Draupnir Bio ApS. (7/1//24). "Press Release: Draupnir Bio Completes €12 Million Seed Round to Progress Development of Oral Small Molecule Degraders of Extracellular Proteins". Copenhagen. |
2024-07-17 |
| Integra Therapeutics S.L.. (7/16/24). "Press Release: Integra Therapeutics to Receive up to €10.5 Million from European Commission for Its FiCAT Advanced Therapies Platform". Lausanne & San Francisco, CA. |
2024-07-16 |
| Catalym GmbH. (7/16/24). "Press Release: Catalym Announces New Financing of $150M to Support Broad Phase 2b Development Program for Visugromab". Munich. |
2024-07-16 |
| Asceneuron S.A.. (7/16/24). "Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases". Lausanne & San Francisco, CA. |
2024-07-16 |
| Sotio Biotech a.s.. (7/16/24). "Press Release: Sotio Enters into Multi-Target Antibody Agreement with Biocytogen to Expand ADC Pipeline". Prague & Beijing. |
2024-07-16 |
| Pan Cancer T B.V.. (7/11/24). "Press Release: Pan Cancer T Secures EUR 4.25 Million in Seed Extension Round to Advance Next-generation T Cell Therapies". Rotterdam. |
2024-07-11 |
| HepaRegenix GmbH. (7/10/24). "Press Release: HepaRegeniX Raises €15 Million Series C Round to Advance Clinical Development of HRX-215 for Liver Regeneration". Tübingen. |
2024-07-10 |
| Etherna N.V.. (7/10/24). "Press Release: Antonin (Tony) de Fougerolles Appointed as New Chair of Etherna". Niel. |
2024-07-10 |
| SciRhom GmbH. (7/9/24). "Press Release: SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases". Munich. |
2024-07-09 |
![[LSBNL] Life-Sciences-Benelux.com - The Benelux Life Sciences Web Portal](/images/basics/lsbnl-life-sciences-benelux-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
